Imaging Studies for the Early Detection of Breast Cancer

被引:24
作者
Heywang-Koebrunner, S. H. [1 ]
Schreer, I [2 ]
Heindel, W. [3 ,4 ]
Katalinic, A. [5 ]
机构
[1] Referenzzentrum Mammog Munchen, D-81675 Munich, Germany
[2] Univ Klinikum Schleswig Holstein, Fachbereich Med, Mammazentrum, Kiel, Germany
[3] Referenzzentrum Mammog Munster, Munster, Germany
[4] Univ Klinikum Munster, Inst Klin Radiol, Munster, Germany
[5] Univ Lubeck, Inst Krebsepidemiol, Lubeck, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2008年 / 105卷 / 31-32期
关键词
breast cancer; mammography screening; ultrasonography; magnetic resonance imaging; early detection;
D O I
10.3238/arztebl.2008.0541
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The effectiveness of mammographic screening has been proven at evidence level 1A. Mammography offers the best ratio of benefits to side effects of any screening method tested to date. In this literature review, we ask whether early detection might be improved still further by combining mammography with other imaging modalities. Methods: The authors performed a selective literature search for combined key words in the Medline and Cochrane Library databases from 1/2000 to 11/2007, screened all titles, and evaluated the full text of all original articles. We selected articles for further analysis according to systematic criteria (minimum numbers, avoidance of overlap) and also considered published guidelines. Results: No screening studies of comparable size to those for mammography are available for ultrasound or MRI. Smaller studies have indicated that the use of these two modalities might lead to the detection of additional cancers in selected subgroups. For mass screening an increase in the detection rate of 10% to 15% might become possible. This increase would probably be associated with a tripling of the breast biopsy rate, compared to mammography alone. The number of indeterminate cases in which shortterm follow-up (i. e., at 6 months) would be recommended would increase roughy tenfold with MRI, and to an unknown extent with ultrasound. The related quality-assurance issues remain to be addressed. Discussion: Randomized controlled studies are needed for a realistic assessment of the achievable benefits and unavoidable side effects of combined screening. For women whose risk of breast cancer is not elevated, mammography remains the standard screening method. Dtsch Arztebl Int 2008; 105(31-32):541-7 DOI:10.3238/arztebl.2008.0541
引用
收藏
页码:541 / U29
页数:10
相关论文
共 104 条
  • [11] Systematic review: The long-term effects of false-positive mammograms
    Brewer, Noel T.
    Salz, Talya
    Lillie, Sarah E.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (07) : 502 - 510
  • [12] Clinically and mammographically occult breast lesions:: Detection and classification with high-resolution sonography
    Buchberger, W
    Niehoff, A
    Obrist, P
    DeKoekkoek-Doll, P
    Dünser, M
    [J]. SEMINARS IN ULTRASOUND CT AND MRI, 2000, 21 (04) : 325 - 336
  • [13] Cilotti A, 2002, J EXP CLIN CANC RES, V21, P137
  • [14] Corsetti V, 2006, RADIOL MED, V111, P440, DOI 10.1007/s11547-006-0040-5
  • [15] Using sonography to screen women with mammographically dense breasts
    Crystal, P
    Strano, SD
    Shcharynski, S
    Koretz, MJ
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (01) : 177 - 182
  • [16] Overdiagnosis and overtreatment of breast cancer - Microsimulation modelling estimates based on observed screen and clinical data
    de Koning, HJ
    Draisma, G
    Fracheboud, J
    de Bruijn, A
    [J]. BREAST CANCER RESEARCH, 2006, 8 (01):
  • [17] Delorme S, 2001, RADIOLOGE, V41, P371, DOI 10.1007/s001170051016
  • [18] Clinically and mammographically occult breast lesions on MR images: Potential effect of computerized assessment on clinical reading
    Deurloo, EE
    Muller, SH
    Peterse, JL
    Besnard, APE
    Gilhuijs, KGA
    [J]. RADIOLOGY, 2005, 234 (03) : 693 - 701
  • [19] Reduction in breast cancer mortality from organized service screening with mammography:: 1.: Further confirmation with extended data
    Duffy, SW
    Tabár, L
    Chen, THH
    Smith, RA
    Holmberg, L
    Jonsson, H
    Lenner, P
    Nyström, L
    Törnberg, S
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (01) : 45 - 51
  • [20] Eisinger F, 2005, B CANCER, V92, P874